Point72 Asia Singapore Pte. Ltd. Makes New $1.07 Million Investment in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Point72 Asia Singapore Pte. Ltd. purchased a new position in Intuitive Surgical, Inc. (NASDAQ:ISRG) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 2,179 shares of the medical equipment provider’s stock, valued at approximately $1,070,000.

A number of other large investors have also bought and sold shares of the stock. Kestra Investment Management LLC purchased a new position in Intuitive Surgical in the 3rd quarter worth approximately $380,000. Point72 Hong Kong Ltd purchased a new position in Intuitive Surgical in the 3rd quarter worth approximately $4,397,000. Erste Asset Management GmbH purchased a new position in Intuitive Surgical in the 3rd quarter worth approximately $39,377,000. Cobblestone Capital Advisors LLC NY grew its position in shares of Intuitive Surgical by 9.3% in the 3rd quarter. Cobblestone Capital Advisors LLC NY now owns 1,340 shares of the medical equipment provider’s stock worth $658,000 after buying an additional 114 shares during the last quarter. Finally, Caisse DE Depot ET Placement DU Quebec grew its position in shares of Intuitive Surgical by 15.5% in the 3rd quarter. Caisse DE Depot ET Placement DU Quebec now owns 229,306 shares of the medical equipment provider’s stock worth $112,651,000 after buying an additional 30,724 shares during the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on ISRG shares. Evercore ISI reiterated a “cautious” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Erste Group Bank upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Tuesday, November 19th. Wells Fargo & Company lifted their price objective on Intuitive Surgical from $466.00 to $549.00 and gave the stock an “overweight” rating in a research report on Friday, October 18th. Robert W. Baird lifted their price objective on Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a research report on Thursday, October 17th. Finally, Royal Bank of Canada lifted their price target on Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a research report on Friday, October 18th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have issued a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $526.06.

Intuitive Surgical Price Performance

ISRG stock opened at $542.00 on Monday. Intuitive Surgical, Inc. has a 1-year low of $304.50 and a 1-year high of $552.00. The business has a fifty day moving average price of $510.03 and a 200-day moving average price of $469.49. The stock has a market capitalization of $193.05 billion, a P/E ratio of 87.14, a P/E/G ratio of 5.33 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, topping the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. The firm had revenue of $2.04 billion during the quarter, compared to analysts’ expectations of $2.01 billion. As a group, analysts anticipate that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Insider Transactions at Intuitive Surgical

In related news, CFO Jamie Samath sold 108 shares of the company’s stock in a transaction on Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total transaction of $58,542.48. Following the completion of the sale, the chief financial officer now owns 8,757 shares in the company, valued at approximately $4,746,819.42. This represents a 1.22 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Robert Desantis sold 188 shares of the company’s stock in a transaction on Tuesday, October 29th. The shares were sold at an average price of $506.52, for a total value of $95,225.76. Following the sale, the executive vice president now owns 5,506 shares of the company’s stock, valued at approximately $2,788,899.12. This trade represents a 3.30 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 50,459 shares of company stock worth $26,080,251 over the last quarter. 0.90% of the stock is currently owned by insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.